Breast cancer care across CION centres in Hyderabad · ArogyaSri, CGHS & cashless insurance accepted · Call 1800 202 8726

Your report explained

What is pathological complete response (pCR)?

A pathological complete response means that when the tissue removed at your operation was examined under a microscope, no invasive cancer was found in the breast or the lymph nodes. It is the result the whole approach aims for. This page explains how much it tells you, how that differs by subtype, and why treatment continues.

Call 1800 202 8726

Speak to an oncologist

Book a consultation

Talk to a breast cancer specialist at a CION centre near you.

Free call back. Your details stay private.

NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating

The short answer

What does pathological complete response mean?

It means that when the tissue removed at your operation was examined under a microscope, no invasive cancer was found in the breast or in the lymph nodes. The chemotherapy given before surgery cleared what was visible and what was microscopic. It is written on reports as pCR.

Why it is such a good result

It tells you that your cancer was highly sensitive to the treatment it received. Across many studies, women who achieve it, particularly with triple negative and HER2 positive cancers, have gone on to do better than those with cancer remaining. It is the outcome the whole approach aims for.

What it is not

It is not a promise. It describes what was found in the tissue that was removed, and it cannot see cells that may be elsewhere in the body. This is why radiotherapy and hormone tablets continue as planned afterwards.

On your report

The wording, in plain language

pCR, or pathological complete response
No invasive cancer found in the breast or the nodes at surgery.
ypT0 ypN0
The staging shorthand for the same thing. The y means the staging follows treatment given before surgery.
ypTis
No invasive cancer, but DCIS still present. This still counts as a complete response under the definition most centres use.
Clinical complete response
Nothing could be felt or seen on a scan before surgery. It is not the same thing, and it is much less reliable.
Residual disease
Cancer still present at surgery. The opposite result, and the one that leads to additional treatment.
DCIS
Cancer cells still held inside the milk ducts, which have not invaded surrounding tissue.

Not sure whether this applies to you?

Ask an oncologist

It means different things

How much a complete response tells you, by subtype

The same result carries very different weight depending on what kind of breast cancer you have.

Triple negative

This is where it matters most. Achieving it is strongly reassuring, and not achieving it is the trigger for additional treatment after surgery.

HER2 positive

Complete responses are common with modern HER2 treatment, and are a good sign. Where cancer remains, the treatment given afterwards is usually changed because of it.

Ask what is planned for you either way.

Hormone sensitive, HER2 negative

Complete responses are uncommon here, and their absence is not alarming. These cancers respond slowly to chemotherapy, and the long work is done by hormone tablets over years.

What it changes practically

Mostly what is added after surgery. It does not usually change whether you need radiotherapy, which is decided on what the cancer was at the start.

Usually unchanged by pCR

  • Radiotherapy
  • Hormone tablets, if you are receptor positive
  • The follow-up schedule

Side by side

Two results that sound the same and are not

Clinical complete response Pathological complete response
Nothing felt or seen before surgery Nothing found under the microscope after surgery
Based on examination and scans Based on the tissue itself
Microscopic cancer often still present No invasive cancer present in what was removed
Does not allow surgery to be skipped Comes from the surgery, so the question does not arise
Encouraging, not conclusive The result that carries real weight

Leave a number, we will call you

One field. No form to fill in, and no charge for the call.

Talk to our team

Have a question about your situation?

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

Being straight with you

What a complete response cannot tell you

It cannot tell you that the cancer will never return. A small number of women who achieve it do have a recurrence later, because the result describes the tissue that was removed and not every cell in the body.

Why treatment continues afterwards

Radiotherapy is planned on what the cancer was at the start, not on how well it responded. Hormone tablets continue for years if your cancer is receptor positive. Stopping these on the strength of a good result is the one mistake that could undo the advantage it represents.

It does not change your original stage

Your stage at diagnosis stays on the record, and follow-up is planned around it. Women sometimes assume a complete response resets them to stage zero. It does not, and knowing that avoids confusion later when a new doctor reads the file.

What to do with the result

Take the good news, and then ask two practical questions. What treatment continues from here, and for how long. Write the answers down, because this is the point at which people stop attending appointments and start missing tablets.

Commonly believed

What families conclude from this result

Complete response means she is finished with treatment.

Radiotherapy and hormone tablets usually continue exactly as planned. The complete response tells you the cancer was sensitive to what was given. Finishing the rest of the plan is what preserves that advantage.

It means the cancer cannot come back.

It substantially lowers the risk and it is the best result available, but a small number of women do have a recurrence later. Honest follow-up continues for years, and knowing what symptoms to report still matters.

DCIS left behind means it was not a complete response.

Under the definition most centres use, a complete response means no invasive cancer. DCIS may remain and the result still counts. Your surgeon will still want it removed with a clear margin, which is a separate matter.

My relative did not get pCR, so she did worse.

Not necessarily. In hormone sensitive cancers a complete response is uncommon and its absence means very little, because those cancers are controlled by tablets over years rather than cleared by chemotherapy. Comparing across subtypes is not meaningful.

After the result

What still continues, and for how long

  1. Healing from surgery

    A few weeks before anything else begins. Tell your team about any wound problem rather than waiting, because a delay here pushes everything that follows back.

  2. Radiotherapy, in most cases

    Planned on what the cancer was at diagnosis and on the operation you had, not on how well it responded. A complete response does not usually remove the need for it.

  3. HER2 treatment, if it applies

    Where your cancer was HER2 positive, targeted treatment generally continues to complete a full year from when it started. Ask for the finish date in writing.

  4. Hormone tablets, if you are receptor positive

    These run for years and do the long-term work. This is the part that most often lapses once people feel well, and the part where stopping early measurably raises risk.

  5. Follow-up appointments

    Planned around your stage at diagnosis rather than your response. Ask for the schedule, who to telephone between visits, and how quickly you can be seen if something changes.

Questions we are asked

Common questions about complete response

Am I cancer free?

No invasive cancer was found in the tissue removed, which is the best result this test can give. It is not the same as a promise that no cell survives anywhere, which is why the rest of your treatment continues. Most oncologists will say the result is excellent and still ask you to finish the plan.

Do I still need radiotherapy?

Usually yes. Radiotherapy is decided on what the cancer was at diagnosis and on the operation you had, not on how well it responded. Your radiation oncologist will explain which areas are being treated and why.

Can I stop my hormone tablets?

No. If your cancer was receptor positive, the tablets continue for years and they are doing the long-term work. Stopping early is one of the few decisions that measurably raises the risk of recurrence. If side effects are the problem, say so, because the tablet can usually be changed.

Does this mean I needed less surgery?

The surgery is what produced the result, so it could not have been skipped. Shrinkage often does allow a smaller operation than was first planned, and for many women that is the practical benefit of having chemotherapy first.

How common is it?

It varies enormously by subtype. It is reasonably common in HER2 positive and triple negative cancers treated with modern regimens, and uncommon in hormone sensitive, HER2 negative disease. Ask your oncologist what was realistic for your own subtype.

Will my follow-up be shorter?

Generally not. Follow-up is planned around your stage at diagnosis and the treatment you had. You may feel less anxious at appointments, which is a real benefit, but the schedule itself usually stays the same.

Does it change my risk of it appearing in the other breast?

Not directly. That risk is driven by your inherited risk and your hormone status, and hormone tablets reduce it where they apply. Your other breast continues to be screened yearly, and that should not lapse.

Should I ask for the result in writing?

Yes, and keep it with your pathology report. It is a result you will be asked about by every doctor you see for years, including if you move city or change hospital. Having the wording itself saves a great deal of confusion later.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Where to find us

Our centres in and around Hyderabad

Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.

CION Ameerpet

Beside Blue Fox Hotel, Satyam Theatre Road

Begumpet SR Nagar Punjagutta
CION Kukatpally

Opposite Big Bazaar, Mumbai Highway

KPHB JNTU Bharat Nagar
CION L.B. Nagar

Anu Arcade, next to L.B. Nagar Metro station

Vanasthalipuram Nagole Hayathnagar
CION Tolichowki

Inside Premier Hospital, Khader Bagh Road

Mehdipatnam Attapur Rethibowli
CION Masab Tank

Mahavir Hospital, AC Guards, Lakdikapul

Lakdikapul Khairatabad Basheer Bagh
CION Banjara Hills

Road No. 12

Jubilee Hills Madhapur Film Nagar
CION Kompally

Suchitra Circle, NH-44

Suchitra Circle Alwal Dundigal
CION Balanagar

Balanagar Main Road

Balanagar Fatehnagar Moosapet
CION Siddipet

Lohith Sai Hospital, Shivaji Nagar

Gajwel Husnabad Dubbaka
CION Sangareddy

X Roads, Pothreddipalle

Narayankhed Zaheerabad Patancheru

Talk to our team

Speak to a breast cancer specialist

Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.

Call 1800 202 8726 Helpline open 24/7

Request a call back

Share your number and a specialist's team will call you.

Free call back. Your details stay private.

Sources

  1. Cancer Research UK — Chemotherapy before surgery for breast cancer
  2. National Cancer Institute — Pathologic complete response
  3. Breast Cancer Now — Chemotherapy before surgery

This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.

Call 1800 202 8726Book a consultation
Explore more

Breast Cancer Topics

Browse our complete guide to breast cancer — types, symptoms, tests and treatments. Tap any topic to read more.

HER2-Targeted Therapy

Cost of a full year of HER2 therapy in India De-escalated HER2 treatment for small tumours What happens if your heart function drops during treatment? Ejection fraction monitoring on HER2 therapy HER2-low breast cancer HER2-positive and hormone-positive together The full HER2 treatment pathway How does pertuzumab work, and who is it for? How does trastuzumab emtansine work, and who is it for? How long will you be on pertuzumab? Is adding pertuzumab worth the extra cost? Missed a dose of pertuzumab? What to do Missed a dose of trastuzumab emtansine? What to do Neratinib as extended adjuvant HER2 therapy Pertuzumab, fertility, menopause and sexual health How much does pertuzumab actually help? The numbers explained Pertuzumab cost in India Diarrhoea and rash on pertuzumab Heart function monitoring on dual HER2 blockade Pertuzumab infusion day Medicines, foods and supplements to avoid on pertuzumab Tests and monitoring while you are on pertuzumab Pertuzumab myths Pertuzumab (Perjeta) for breast cancer Pertuzumab side effects Pertuzumab T-DM1 infusion day Liver enzyme rises and nerve changes on T-DM1 Low platelets and bleeding risk on T-DM1 T-DM1 myths T-DM1 vs continuing trastuzumab after residual disease Trastuzumab emtansine (T-DM1) after residual disease Trastuzumab biosimilars in India Trastuzumab emtansine, fertility, menopause and sexual health How much does trastuzumab emtansine actually help? The numbers explained Trastuzumab emtansine cost in India Medicines, foods and supplements to avoid on trastuzumab emtansine Trastuzumab emtansine side effects Trastuzumab emtansine (Kadcyla) for breast cancer Lapatinib and tucatinib Why exactly twelve months of trastuzumab?

Hormone Therapy Medicines

Anastrozole, fertility, menopause and sexual health How much does anastrozole actually help? The numbers explained Anastrozole cost in India Medicines, foods and supplements to avoid on anastrozole Cholesterol, bone density and long-term effects of anastrozole Tests and monitoring while you are on anastrozole Anastrozole myths Anastrozole side effects Anastrozole vs tamoxifen Anastrozole (Arimidex) for breast cancer Exemestane, fertility, menopause and sexual health How much does exemestane actually help? The numbers explained Exemestane cost in India Medicines, foods and supplements to avoid on exemestane Joint pain and fatigue on exemestane Tests and monitoring while you are on exemestane Exemestane myths Exemestane side effects Why exemestane is taken after food and its steroidal effects Exemestane (Aromasin) for breast cancer Fulvestrant, fertility, menopause and sexual health How much does fulvestrant actually help? The numbers explained Fulvestrant cost in India Injection site pain and reactions on fulvestrant The fulvestrant injection Medicines, foods and supplements to avoid on fulvestrant Tests and monitoring while you are on fulvestrant Fulvestrant myths Fulvestrant side effects Fulvestrant vs aromatase inhibitors in advanced disease Fulvestrant (Faslodex) for breast cancer How much does goserelin actually help? The numbers explained Bone loss and mood changes on ovarian suppression Goserelin cost in India The goserelin implant Medicines, foods and supplements to avoid on goserelin Sudden menopause symptoms from ovarian suppression Tests and monitoring while you are on goserelin Goserelin myths Goserelin side effects Goserelin injections vs surgical ovary removal Goserelin (Zoladex) for breast cancer Hot flushes, joint pain and fatigue on fulvestrant How does anastrozole work, and who is it for? How does exemestane work, and who is it for? How does fulvestrant work, and who is it for? How does goserelin work, and who is it for? How does letrozole work, and who is it for? Postmenopausal hormone-receptor-positive breast cancer How long will you be on anastrozole? How long will you be on exemestane? How long will you be on fulvestrant? How long will you be on goserelin? How long will you be on letrozole? Taking anastrozole Taking exemestane Taking letrozole Letrozole, fertility, menopause and sexual health How much does letrozole actually help? The numbers explained Bone thinning on letrozole Letrozole cost in India Medicines, foods and supplements to avoid on letrozole Joint pain and morning stiffness on letrozole Tests and monitoring while you are on letrozole Letrozole myths Letrozole side effects Letrozole vs anastrozole vs exemestane Letrozole (Femara) for breast cancer Missed a dose of anastrozole? What to do Missed a dose of exemestane? What to do Missed a dose of fulvestrant? What to do Missed a dose of goserelin? What to do Missed a dose of letrozole? What to do Exemestane after letrozole or anastrozole Will your periods and fertility return after stopping goserelin?

Targeted & Newer Medicines

Abemaciclib, fertility, menopause and sexual health How much does abemaciclib actually help? The numbers explained Abemaciclib cost in India Diarrhoea on abemaciclib Two years of abemaciclib after surgery Medicines, foods and supplements to avoid on abemaciclib Tests and monitoring while you are on abemaciclib Abemaciclib myths Abemaciclib side effects Abemaciclib vs other CDK4/6 inhibitors Abemaciclib (Verzenio) for breast cancer CDK4/6 inhibitors in early breast cancer after surgery Adjuvant olaparib after surgery for BRCA carriers Alpelisib, fertility, menopause and sexual health How much does alpelisib actually help? The numbers explained Alpelisib cost in India High blood sugar on alpelisib Medicines, foods and supplements to avoid on alpelisib Tests and monitoring while you are on alpelisib Alpelisib myths Alpelisib (Piqray) for breast cancer Rash and mouth sores on alpelisib Alpelisib side effects Alpelisib vs everolimus after endocrine therapy fails Alpelisib for PIK3CA-mutated breast cancer CDK4/6 inhibitors in breast cancer Everolimus in hormone-resistant breast cancer How does abemaciclib work, and who is it for? How does ribociclib work, and who is it for? How does sacituzumab govitecan work, and who is it for? How long will you be on alpelisib? How long will you be on ribociclib? How long will you be on sacituzumab govitecan? Taking abemaciclib Taking alpelisib Taking ribociclib Liquid biopsy in metastatic breast cancer Missed a dose of abemaciclib? What to do Missed a dose of alpelisib? What to do Missed a dose of ribociclib? What to do Missed a dose of sacituzumab govitecan? What to do Newer drugs Elacestrant and oral SERDs for ESR1-mutant disease PARP inhibitors for BRCA-mutated breast cancer Do you need a PIK3CA test before alpelisib? Ribociclib, fertility, menopause and sexual health How much does ribociclib actually help? The numbers explained Ribociclib cost in India ECG monitoring and QT prolongation on ribociclib Medicines, foods and supplements to avoid on ribociclib Low white cell counts on ribociclib Tests and monitoring while you are on ribociclib Ribociclib myths Ribociclib side effects Ribociclib (Kisqali) for breast cancer Sacituzumab govitecan, fertility, menopause and sexual health How much does sacituzumab govitecan actually help? The numbers explained Sacituzumab govitecan cost and availability in India Diarrhoea on sacituzumab govitecan and how it is managed Medicines, foods and supplements to avoid on sacituzumab govitecan Tests and monitoring while you are on sacituzumab govitecan Sacituzumab govitecan myths Low counts, fever risk and hair loss on sacituzumab govitecan Sacituzumab govitecan infusion days Sacituzumab govitecan side effects Sacituzumab govitecan for triple-negative breast cancer Sacituzumab govitecan vs standard chemotherapy in triple negative breast cancer How newer drugs are sequenced with older ones

Metastatic Breast Cancer

What comes after a CDK4/6 inhibitor stops working? Ascites and abdominal swelling in advanced breast cancer Is my back pain bone metastasis or something else? Bone marrow involvement in advanced breast cancer Bone metastases in breast cancer Brain metastases in breast cancer Tumour markers CA 15-3 and CEA in metastatic breast cancer Chest wall and local recurrence after mastectomy Clinical trials in metastatic breast cancer Cost of long-term metastatic breast cancer treatment in India Explaining metastatic breast cancer to family and friends First-line treatment for hormone-positive metastatic breast cancer Confusion, thirst and drowsiness Lines of treatment in metastatic breast cancer Liver metastases in breast cancer Living well with metastatic breast cancer for years Lung metastases and pleural effusion in breast cancer Malignant pleural effusion Metastatic breast cancer and pink-ribbon culture Prognosis in metastatic breast cancer Treatment sequence in metastatic HER2-positive breast cancer Treatment options in metastatic triple negative breast cancer Oligometastatic breast cancer Why receptors are re-tested on a metastatic biopsy Scan intervals and monitoring in metastatic disease Understanding scan reports in metastatic breast cancer Skin metastases and nodules on the chest Surgery and radiation in metastatic breast cancer Treatment holidays and breaks in metastatic breast cancer When do doctors switch treatment in metastatic disease? Where breast cancer spreads and what each site feels like Working and earning with metastatic breast cancer
Call now Book free consultation